Eli Lilly's tirzepatide, marketed under the brands Mounjaro for diabetes and Zepbound for weight management, is highly ...
Eli Lilly said in August that around 50 percent of employers had chosen to cover its weight-loss drug, Zepbound, little changed from a year earlier. Novo Nordisk said last month that about 40 million ...
WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback